Next-Generation mRNA Capping Technologies Market
完整報告名稱與涵蓋範圍
Next-Generation mRNA Capping Technologies Market Size, Share & Trends Analysis Distribution by Technology Type (Co-transcriptional Capping, Post-transcriptional Enzymatic Capping, Novel/Upcoming mRNA Capping Technology), Product Type (Cap Analogs, Capping Kits, Custom mRNA Synthesis Services), Application (mRNA Vaccines, mRNA Therapeutics, Research Tools, Emerging Applications), End-User (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organizations (CDMOs), Academic & Research Institutes) and Segment Forecasts, 2025-2034
報告摘要
A CAGR of 9.7% is forecasted for the global Next-Generation mRNA Capping Technologies Market over the assessment period of 2025 through 2034.
Next-Generation mRNA Capping Technologies covers advanced techniques developed to optimize the addition of the 5′ cap structure to synthetic mrna molecules. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Several factors contribute to this trajectory, including heightened call for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region projected to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Next-Generation mRNA Capping Technologies Market Snapshot
Chapter 4. Global Next-Generation mRNA Capping Technologies Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Global Next-Generation mRNA Capping Technologies Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Comaprison of Key Technologies/Offerings
4.10.1. CleanCap – TriLink BioTechnologies (USA)
4.10.2. AvantCap – ExPLoRNA Therapeutics (Poland)
4.10.3. LZCap – Guangzhou Henovcom Bioscience Co., Ltd. (China)
4.10.4. β-S-ARCA – Commercialized by players such as Jena Bioscience (Germany)
4.11. Clinical Trial/Pipeline Analysis of Non-COVID mRNA Products
4.12. Use/impact of AI on mRNA Industry Trends
Chapter 5. Next-Generation mRNA Capping Technologies Market Segmentation 1: By Technology Type, Estimates & Trend Analysis
5.1. Market Share by Technology Type, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology Type:
5.2.1. Co-transcriptional Capping
5.2.2. Post-transcriptional Enzymatic Capping
5.2.3. Novel/Upcoming mRNA Capping Technology
Chapter 6. Next-Generation mRNA Capping Technologies Market Segmentation 2: By Product Type, Estimates & Trend Analysis
6.1. Market Share by Product Type, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product Type:
6.2.1. Cap Analogs
6.2.2. Capping Kits
6.2.3. Custom mRNA Synthesis Services
Chapter 7. Next-Generation mRNA Capping Technologies Market Segmentation 3: By Application , Estimates & Trend Analysis
7.1. Market Share by Application , 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application :
7.2.1. mRNA Vaccines
7.2.2. mRNA Therapeutics
7.2.3. Research Tools
7.2.4. Emerging Applications (e.g., saRNA, circRNA, Gene Editing)
Chapter 8. Next-Generation mRNA Capping Technologies Market Segmentation 4: By End-User, Estimates & Trend Analysis
8.1. Market Share by End-User, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-User:
8.2.1. Pharmaceutical & Biotechnology Companies
8.2.2. Contract Development & Manufacturing Organizations (CDMOs)
8.2.3. Academic & Research Institutes
Chapter 9. Next-Generation mRNA Capping Technologies Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Next-Generation mRNA Capping Technologies Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.2.3. North America Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
9.2.4. North America Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Application , 2021-2034
9.2.5. North America Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.3. Europe
9.3.1. Europe Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.3.3. Europe Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
9.3.4. Europe Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Application , 2021-2034
9.3.5. Europe Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.4.3. Asia Pacific Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
9.4.4. Asia Pacific Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts By Application , 2021-2034
9.4.5. Asia Pacific Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.5. Latin America
9.5.1. Latin America Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.5.3. Latin America Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
9.5.4. Latin America Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Application , 2021-2034
9.5.5. Latin America Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.6.3. Middle East & Africa Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
9.6.4. Middle East & Africa Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by Application , 2021-2034
9.6.5. Middle East & Africa Next-Generation mRNA Capping Technologies Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Hanmi Fine Chemical (Hanmi Pharmaceutical)
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Synthgene
10.2.3. Aldevron
10.2.4. BOC Sciences
10.2.5. GenScript Biotech Corporation
10.2.6. Hongene Biotech Corporation
10.2.7. Creative Biolabs
10.2.8. TriLink BioTechnologies
10.2.9. ExPLoRNA Therapeutics
10.2.10. Guangzhou Henovcom Bioscience
10.2.11. GenScript Biotech Corporation
10.2.12. Jena Bioscience
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們